#Sovaldi

One of the first celebrities to disclose she had hepatitis C—and was cured of the liver disease—Pamela Anderson will star in “Chicago."

A four-drug combination cured all individuals who had experienced prior treatment failure.

Sofosbuvir-based regimens were well tolerated and cure rates were high in this population.

With many hepatitis C treatments on the market today, patients may ask which hepatitis C treatment is right for me? What’s the difference?

The Supreme Court refused to hear Merck’s arguments on a hepatitis C patent, so the previous ruling in Gilead’s favor stands.

Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.

In a recent British Columbia study, 1 in 10 people who began treatment were lost to follow-up.

Though low, this figure is three times the rate of discontinuation seen in clinical trials.

Danish researchers followed 71 people who were cured with Sovaldi-based treatment.

A recent mid-stage trial that combined coblopasvir with Sovaldi (sofosbuvir) boasted a high cure rate.

A U.S. appeals court upheld a judge’s previous decision to throw out a record-setting 2016 verdict in Merck’s favor.

The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.

September 4, 2019, the U.S. FDA released their recent approval of new dosage forms of Sovaldi and Harvoni for children 3 to 12 years of age.

Health advocate David Whiters has mastered some smooth moves since overcoming addiction and hep C.